236 related articles for article (PubMed ID: 33206204)
1. Human pituitary development and application of iPSCs for pituitary disease.
Matsumoto R; Takahashi Y
Cell Mol Life Sci; 2021 Mar; 78(5):2069-2079. PubMed ID: 33206204
[TBL] [Abstract][Full Text] [Related]
2. Congenital pituitary hypoplasia model demonstrates hypothalamic OTX2 regulation of pituitary progenitor cells.
Matsumoto R; Suga H; Aoi T; Bando H; Fukuoka H; Iguchi G; Narumi S; Hasegawa T; Muguruma K; Ogawa W; Takahashi Y
J Clin Invest; 2020 Feb; 130(2):641-654. PubMed ID: 31845906
[TBL] [Abstract][Full Text] [Related]
3. From Pituitary Stem Cell Differentiation to Regenerative Medicine.
Camilletti MA; Martinez Mayer J; Vishnopolska SA; Perez-Millan MI
Front Endocrinol (Lausanne); 2020; 11():614999. PubMed ID: 33542708
[TBL] [Abstract][Full Text] [Related]
4. Functional Pituitary Tissue Formation.
Ozone C; Suga H
Methods Mol Biol; 2017; 1597():57-65. PubMed ID: 28361310
[TBL] [Abstract][Full Text] [Related]
5. Derivation of Diverse Hormone-Releasing Pituitary Cells from Human Pluripotent Stem Cells.
Zimmer B; Piao J; Ramnarine K; Tomishima MJ; Tabar V; Studer L
Stem Cell Reports; 2016 Jun; 6(6):858-872. PubMed ID: 27304916
[TBL] [Abstract][Full Text] [Related]
6. Making pituitary hormone-producing cells in a dish [Review].
Suga H
Endocr J; 2016 Aug; 63(8):669-80. PubMed ID: 27245938
[TBL] [Abstract][Full Text] [Related]
7. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
8. Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology.
Easley CA
Methods Mol Biol; 2019; 1965():19-34. PubMed ID: 31069666
[TBL] [Abstract][Full Text] [Related]
9. Development of the Pituitary Gland.
Alatzoglou KS; Gregory LC; Dattani MT
Compr Physiol; 2020 Mar; 10(2):389-413. PubMed ID: 32163208
[TBL] [Abstract][Full Text] [Related]
10. EpCAM Is a Surface Marker for Enriching Anterior Pituitary Cells From Human Hypothalamic-Pituitary Organoids.
Kodani Y; Kawata M; Suga H; Kasai T; Ozone C; Sakakibara M; Kuwahara A; Taga S; Arima H; Kameyama T; Saito K; Nakashima A; Nagasaki H
Front Endocrinol (Lausanne); 2022; 13():941166. PubMed ID: 35903276
[TBL] [Abstract][Full Text] [Related]
11. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
12. Pluripotent stem cells in regenerative medicine: challenges and recent progress.
Tabar V; Studer L
Nat Rev Genet; 2014 Feb; 15(2):82-92. PubMed ID: 24434846
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids.
Qu Y; Han B; Gao B; Bose S; Gong Y; Wawrowsky K; Giuliano AE; Sareen D; Cui X
Stem Cell Reports; 2017 Feb; 8(2):205-215. PubMed ID: 28132888
[TBL] [Abstract][Full Text] [Related]
14. Traumatic brain injury and resultant pituitary dysfunction: insights from experimental animal models.
Vennekens A; Vankelecom H
Pituitary; 2019 Jun; 22(3):212-219. PubMed ID: 31020506
[TBL] [Abstract][Full Text] [Related]
15. Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications.
Liu G; David BT; Trawczynski M; Fessler RG
Stem Cell Rev Rep; 2020 Feb; 16(1):3-32. PubMed ID: 31760627
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells.
Yamashita T; Miyamoto Y; Bando Y; Ono T; Kobayashi S; Doi A; Araki T; Kato Y; Shirakawa T; Suzuki Y; Yamauchi J; Yoshida S; Sato N
PLoS One; 2017; 12(2):e0171947. PubMed ID: 28192470
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Differentiation of Pluripotent Stem Cells into Functional β Islets Under 2D and 3D Culture Conditions and In Vivo Preclinical Validation of 3D Islets.
Bose B; Sudheer PS
Methods Mol Biol; 2016; 1341():257-84. PubMed ID: 25783769
[TBL] [Abstract][Full Text] [Related]
18. In vitro generation of human pluripotent stem cell derived lung organoids.
Dye BR; Hill DR; Ferguson MA; Tsai YH; Nagy MS; Dyal R; Wells JM; Mayhew CN; Nattiv R; Klein OD; White ES; Deutsch GH; Spence JR
Elife; 2015 Mar; 4():. PubMed ID: 25803487
[TBL] [Abstract][Full Text] [Related]
19. Application of pluripotent stem cells for treatment of human neuroendocrine disorders.
Suga H
Cell Tissue Res; 2019 Jan; 375(1):267-278. PubMed ID: 30078102
[TBL] [Abstract][Full Text] [Related]
20. Manipulations of microRNA in human pluripotent stem cells and their derivatives.
Rushing SN; Herren AW; Lieu DK; Li RA
Methods Mol Biol; 2011; 690():107-20. PubMed ID: 21042988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
